Related content

The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid

By Donald P.   Parkin D.   Seifart H.   Schaaf H.   Helden P.   Werely C.   Sirgel F.   Venter A.   Maritz J.  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 7, 2007-07 ,pp. : 633-639

Springer Publishing Company

Access to resources Recommend Favorite

Dose-escalation study of isoniazid in healthy volunteers with the rapid acetylator genotype of arylamine N-acetyltransferase 2

By Kubota Ryuji   Ohno Masako   Hasunuma Tomoko   Iijima Hajime   Azuma Junichi  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 927-933

Springer Publishing Company

Access to resources Recommend Favorite

Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals

By Bakayev Valery   Mohammadi Forozan   Bahadori Moslem   Sheikholslami Mariam   Javeri Arash   Masjedi Mohammad   Velayati Ali  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 7, 2004-09 ,pp. : 467-471

Springer Publishing Company

Access to resources Recommend Favorite

Genetic Polymorphism in N-Acetyltransferase (NAT): Population Distribution of NAT1 and NAT2 Activity

By Walker Katy  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 440-472

Taylor & Francis Ltd

Access to resources Recommend Favorite

The effect of Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s, N-acetyltransferase 2 and xanthine oxidase, in extensive or intermediate metabolizers of CYP2D6

By Nakao Masashi   Muramoto Yousuke   Hisadome Motoko   Yamano Naoko   Shoji Mami   Fukushima Yumi   Saruwatari Junji   Nakagawa Kazuko  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 4, 2007-04 ,pp. : 345-353

Springer Publishing Company

Access to resources Recommend Favorite